• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • Login
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • Experts on Demand
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • Cell and Gene Therapy
    • View Webinars On-Demand
    • The “True” In Vitro Diagnostics Market: $117 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login

acquisitions

  • Sort by Random
    • Default
    • Custom
    • Name
    • Price
    • Date
    • Popularity (sales)
    • Average rating
    • Relevance
    • Random
    • Product ID
  • Display 15 Products per page
    • 15 Products per page
    • 30 Products per page
    • 45 Products per page
    Cell and Gene Therapy Business Outlook

    Published: January 1, 2022 | Price: $4,995 – $30,000

    How Do You Plan to Keep Up With Developments in The Business of Cell and Gene Therapy in 2022? Consider Cell and Gene Therapy Business Outlook Each week brings news in Cell and Gene Therapy, from advances in clinical trials to product launches, from tools development to mergers and acquisitions.  It can be a daunting task to keep up.  Yet these developments are too fast-moving and significant for healthcare companies of any type to ignore.  Now from Science and Medicine...
    In Vitro Diagnostics Business Outlook

    Published: January 1, 2022 | Price: $4,995 – $30,000

    From Kalorama Information and Science and Medicine Group (publishers of Instrument Business Outlook) comes a new publication focusing on the business of clinical testing. In Vitro Diagnostics Business Outlook offers the following: Market Sizing and Forecasting of IVD Market Segments in Every Issue Clinical Chemistry, Infectious Disease Testing, Oncology, Hematology, Blood Banking, Coagulation, Point of Care–Updates on the Important Test Categories You Need to Know About Industry Watch – Developments with COVID-19 and Other Testing   M&A, Distribution, Partnerships Tracked...

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Contact Us

  •  Email Us: Customer Service

  •  Phone (US):  703-778-3080

  •  Fax:  703-778-3081

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • American College of Physicians Discourages DTC Genetic Testing August 11, 2022
  • This Week in Cell and Gene Therapy: 10 New Developments to Know (August 9, 2022) August 9, 2022
  • What You May Have Missed at AACC 2022: Free White Paper August 5, 2022
  • IVD in India: Growing, Aging Population Impacts Healthcare August 4, 2022
  • Perkin Elmer Splits Analytical and IVD/Life Science Companies August 2, 2022

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Scroll to top
Register for Access Login for Access

Register for Access Login for Access

Lost your password? Register